Recognition affirms Binance's position as a leading CeFi platform built on scale, security, and user trustABU DHABI, UAE, June 11, 2026 /CNW/ -- Binance,...
PTS-G Swarm 1 Delivery Order award advances Viasat’s mini-GEO dual X/Ka-band satellite system into production for resilient, maneuverable, anti-jam military communications
PTS-G Swarm 1 Delivery Order award advances Viasat’s mini-GEO dual X/Ka-band satellite system into production for resilient, maneuverable, anti-jam military communications
CALGARY, AB, June 11, 2026 /PRNewswire/ - (TSXV: GRD) (OTC: GRDAF) - Grounded Lithium Corp. ("GLC" or the "Company") is pleased to provide an operational...
ABU DHABI, UAE, June 11, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) announced that its wholly-owned subsidiary, Neurovia AI, officially participated in the 2026...
Creates a premier, global powertrain leader focused on commercial and light vehicles with approximately $11 billion in sales and approximately $1.7 billion adjusted EBITDA...
Market Activation / Brand VisibilityAs Title Sponsor, Vision Marine Technologies converted a high-visibility California electric boating event into direct product exposure, completing approximately 60...
Greenfield facility in Madhya Pradesh to support 'Make in India' vision and strengthen Haleon's commitment to delivering better everyday healthStrategic oral health-focused site designed...
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.